Skip to main content
HairCited

Ketoconazolo per Alopecia androgenetica

A Evidenze Più grandi trial clinici mostrano in modo costante benefici significativi.

Basato su 17 studi (3 meta-analyses, 2 RCTs) con 5,154 partecipanti totali. 16/17 studi mostrano effetti positivi.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dketoconazole\u0026condition\u003Dandrogenetic\u002Dalopecia'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

In sintesi

Ketoconazole shampoo has strong evidence supporting its use for androgenetic alopecia, working through both antifungal and anti-androgenic mechanisms, and is recommended as a complement to other hair loss approaches.

  • 16 out of 17 studies show positive effects across 5,154 participants
  • Works through dual mechanisms: antifungal scalp benefits and local anti-androgenic activity
  • Included in clinical guidelines as a complementary approach for pattern hair loss
  • Typically used as a 1-2% shampoo applied 2-3 times per week

Key Study Findings

Review
Scalp Microbiome Alterations in Androgenetic Alopecia: Patterns and Emerging Mechanistic Insights.
Dose: None vs: None Outcome: scalp microbiome alterations in androgenetic alopecia Effetto: None None

Popolazione: patients with androgenetic alopecia

laboratory/in vitro 26 weeks
Personalized Compounded Hair Loss Treatments: A Compatibility Assessment of the TrichoConcept™ Vehicle Line.
Dose: F1: biotin 0.5%, caffeine 2.0%, niacinamide 2.0%; F2: finasteride 0.1%, minoxidil 1.0%, tretinoin 0. vs: Placebo Effetto: F1 and F3 stable for 180 days; F2 stable for 14 days; F4 and F5 stable for 150 days; F6/F7 stable fo None
Review
A Canadian Consensus on Androgenetic Alopecia: Approach and Management.
Dose: None vs: Placebo Effetto: None None
systematic review
Management of androgenic alopecia: a systematic review of the literature.
Dose: various across 141 included studies vs: Placebo Effetto: multiple treatments shown to successfully promote hair growth; superiority of multifaceted individua None
Systematic Review n=318
Topical ketoconazole for the treatment of androgenetic alopecia: A systematic review.
Dose: None vs: Placebo Effetto: Increased hair shaft diameter; significant increase in pilary index; clinical improvement by photogr None
narrative review
Topical Antiandrogen Therapies for Androgenetic Alopecia and Acne Vulgaris.
Dose: varies vs: Placebo Effetto: None None

Key Statistics

19

Studi

5154

Partecipanti

Positive

A

Grado

Referenced Papers

Journal of cosmetic … 2024 11 citazioni
Alternative therapies in … 2020 11 citazioni
Current problems in … 2015 8 citazioni
Giornale italiano di … 2014 8 citazioni
International journal of … 2013

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosaggi di uso comune

topical:
2% shampoo, 2-3x/week

Limite massimo: Topical only for hair loss

Dosaggi studiati nella ricerca

Dosaggio Durata Effetto N
None -- Negative --
F1: biotin 0.5%, caffeine 2.0%, niacinamide 2.0%; F2: finasteride 0.1%, minoxidil 1.0%, tretinoin 0. 26 weeks Positive --
None -- Positive --
various across 141 included studies -- Positive --
None -- Positive 318
varies -- Positive --
dutasteride and ketoconazole at pharmacokinetic study doses in rats (not specified in abstract) -- Mixed --
various topical ketoconazole formulations -- Positive 4566

Momento migliore per l'assunzione: Lather on scalp and leave for 3-5 minutes before rinsing; use 2-3 times per week

Safety & Side Effects

Effetti collaterali segnalati

  • Scalp dryness and irritation
  • Changes in hair texture
  • Oily or dry scalp (paradoxical)
  • Contact dermatitis (rare)

Interazioni note

  • Other topical hair treatments (apply at separate times)
  • Systemic ketoconazole has many interactions but topical has minimal systemic absorption

Livello di assunzione massimo tollerabile: Topical only for hair loss

Consultare sempre il proprio medico prima di iniziare qualsiasi integratore.Consultate sempre il vostro medico prima di iniziare qualsiasi integratore.

Frequently Asked Questions

Does Ketoconazolo help with Alopecia androgenetica?
Based on 19 studies with 5,154 participants, there is strong evidence from multiple clinical trials that Ketoconazolo may support Alopecia androgenetica management. Our evidence grade is A (Strong Evidence).
How much Ketoconazolo should I take for Alopecia androgenetica?
Studies have used various dosages. A commonly studied range is 2% shampoo, 2-3x/week. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Ketoconazolo?
Reported side effects may include Scalp dryness and irritation, Changes in hair texture, Oily or dry scalp (paradoxical), Contact dermatitis (rare). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Ketoconazolo and Alopecia androgenetica?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 19 peer-reviewed studies with 5,154 total participants. The overall direction of effect is positive.

References

  1. [1] Aditya K Gupta et al.. Int J Dermatol. 2026. Scalp Microbiome Alterations in Androgenetic Alopecia: Patterns and Emerging Mechanistic Insights. doi:10.1111/ijd.70365 PubMed
  2. [2] Ian Landells et al.. J Cutan Med Surg. 2025. A Canadian Consensus on Androgenetic Alopecia: Approach and Management. doi:10.1177/12034754251368849 PubMed
  3. [3] Carolina Schettino Kegele et al.. Int J Pharm Compd. 2025. Personalized Compounded Hair Loss Treatments: A Compatibility Assessment of the TrichoConcept™ Vehicle Line. PubMed
  4. [4] Amanda Rosenthal et al.. J Cosmet Laser Ther. 2024. Management of androgenic alopecia: a systematic review of the literature. doi:10.1080/14764172.2024.2362126 PubMed
  5. [5] Jaime R Fields et al.. Dermatol Ther. 2020. Topical ketoconazole for the treatment of androgenetic alopecia: A systematic review. doi:10.1111/dth.13202 PubMed
  6. [6] Dustin H Marks et al.. Am J Clin Dermatol. 2020. Topical Antiandrogen Therapies for Androgenetic Alopecia and Acne Vulgaris. doi:10.1007/s40257-019-00493-z PubMed
  7. [7] Solmaz Asnaashari et al.. Altern Ther Health Med. 2020. Herbal Medicines For Treatment of Androgenic Alopecia. PubMed
  8. [8] Franchesca D Choi et al.. J Dermatolog Treat. 2019. Topical ketoconazole: a systematic review of current dermatological applications and future developments. doi:10.1080/09546634.2019.1573309 PubMed
  9. [9] Seong-Wook Seo et al.. Pharmaceutics. 2019. In Vitro and In Vivo Assessment of Metabolic Drug Interaction Potential of Dutasteride with Ketoconazole. doi:10.3390/pharmaceutics11120673 PubMed
  10. [10] Motomu Manabe et al.. J Dermatol. 2018. Guidelines for the diagnosis and treatment of male-pattern and female-pattern hair loss, 2017 version. doi:10.1111/1346-8138.14470 PubMed
  11. [11] Dimitrios Ioannides et al.. Curr Probl Dermatol. 2015. Female pattern hair loss. doi:10.1159/000369404 PubMed
  12. [12] Muhsin A Aldhalimi et al.. ISRN Pharmacol. 2014. Promotive effect of topical ketoconazole, minoxidil, and minoxidil with tretinoin on hair growth in male mice. doi:10.1155/2014/575423 PubMed
  13. [13] B M Piraccini et al.. G Ital Dermatol Venereol. 2014. Androgenetic alopecia. PubMed
  14. [14] Lauren L Levy et al.. Int J Womens Health. 2013. Female pattern alopecia: current perspectives. doi:10.2147/IJWH.S49337 PubMed
  15. [15] K J McElwee et al.. Skin Therapy Lett. 2012. Promising therapies for treating and/or preventing androgenic alopecia. PubMed
  16. [16] A W Rafi et al.. ISRN Dermatol. 2011. Pilot Study of 15 Patients Receiving a New Treatment Regimen for Androgenic Alopecia: The Effects of Atopy on AGA. doi:10.5402/2011/241953 PubMed
  17. [17] Andreas D Katsambas et al.. Clin Dermatol. 2010. Hormonal therapy for acne: why not as first line therapy? facts and controversies. doi:10.1016/j.clindermatol.2009.03.006 PubMed
  18. [18] Shigeki Inui et al.. J Dermatol Sci. 2007. Reversal of androgenetic alopecia by topical ketoconzole: relevance of anti-androgenic activity. doi:10.1016/j.jdermsci.2006.08.011 PubMed
  19. [19] N V Tsiskarishvili et al.. Georgian Med News. 2007. [Effectiveness of the treatment plan for androgenetic alopecia]. PubMed
  20. [20] Ju Jiang et al.. J Dermatol. 2005. Topical application of ketoconazole stimulates hair growth in C3H/HeN mice. doi:10.1111/j.1346-8138.2005.tb00756.x PubMed
  21. [21] B S Hugo Perez. Med Hypotheses. 2004. Ketocazole as an adjunct to finasteride in the treatment of androgenetic alopecia in men. doi:10.1016/s0306-9877(03)00264-0 PubMed
  22. [22] Sujay Khandpur et al.. J Dermatol. 2002. Comparative efficacy of various treatment regimens for androgenetic alopecia in men. doi:10.1111/j.1346-8138.2002.tb00314.x PubMed
  23. [23] C Piérard-Franchimont et al.. Int J Cosmet Sci. 2002. Nudging hair shedding by antidandruff shampoos. A comparison of 1% ketoconazole, 1% piroctone olamine and 1% zinc pyrithione formulations. doi:10.1046/j.1467-2494.2002.00145.x PubMed
  24. [24] C Piérard-Franchimont et al.. Dermatology. 1998. Ketoconazole shampoo: effect of long-term use in androgenic alopecia. doi:10.1159/000017954 PubMed

Avvertenza FDA: Queste affermazioni non sono state valutate dalla Food and Drug Administration. I prodotti e le informazioni presenti su questo sito web non sono destinati a diagnosticare, trattare, curare o prevenire alcuna malattia. I gradi di evidenza presentati si basano sulla nostra analisi della ricerca pubblicata e sottoposta a revisione paritaria e non costituiscono consulenza medica. Consultate sempre il vostro medico prima di iniziare qualsiasi regime di integrazione.